ATAI Stock Analysis: Buy, Sell, or Hold?
ATAI - ATAI Life Sciences N.V. Common Shares
$4.09
0.13 (3.28%)
▲
5d:
-3.54%
30d:
-16.02%
90d:
+7.07%
BUY
HIGH Confidence
Analysis Updated: May 20, 2026 12:00 AM ET
Earnings: May 20, 2026
0d
Get Alerted When ATAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ATAI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ATAI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ATAI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ATAI is currently trading at $4.09, which is considered fair relative to its 30-day fair value range of $3.92 to $4.50.
Technical Outlook: Technically, ATAI is in a strong uptrend. Immediate support is located at $3.90, while resistance sits at $4.46. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+242.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ATAI is in a strong uptrend. Immediate support is located at $3.90, while resistance sits at $4.46. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+242.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.92 -
$4.50
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading 242.3% below Wall St target ($14.00)
Trading Range Analysis
30-Day Trading Range
$3.92 -
$4.50
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.90
Resistance Level
$4.46
Current Trend
Strong Uptrend
Technical data as of
May 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.99
Wall Street Target
$14.00
(+242.3%)
Revenue Growth (YoY)
-38.7%
Earnings Growth (YoY)
-96.8%
Share & Embed Analysis
Last updated: May 20, 2026 6:56 PM ET
Data refreshes hourly during market hours. Next update: 7:56 PM
Data refreshes hourly during market hours. Next update: 7:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin James Craig
SELL
42579 shares
2026-04-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 56 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 64 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 62 BUY |
